Spinocerebellar ataxias types 1, 2 and 3: Age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths

Journal of the Neurological Sciences

Volumn 277, Issue 1-2, 2009, Pages 83-86

  Netravathi, M ^a   Pal, Pramod Kumar ^a   Purushottam, Meera ^a   Thennarasu, Kandavel ^a   Mukherjee, Mitali ^b   Jain, Sanjeev ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

CAG repeat length; Rate of disease progression; Spinocerebellar ataxia

Indexed keywords

REPETITIVE DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; HUMAN; INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RATING SCALE; SPINOCEREBELLAR ATAXIA 1; SPINOCEREBELLAR ATAXIA 2; SPINOCEREBELLAR ATAXIA 3; SPINOCEREBELLAR DEGENERATION;

ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; SEVERITY OF ILLNESS INDEX; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS;

EID: 58149308310     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.10.016     Document Type: Article

References (12)

1. Abe Y., Tanaka F., Matsumoto M., Doyu M., Hirayama M., Kachi T., et al. CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology 51 (1998) 882-884
2. Brandt J., Bylsma F.W., Gross R., Stine O.C., Ranen N., and Ross C.A. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46 (1996) 527-531
3. Doyu M., Sobue G., Mukai E., Kachi T., Yasuda T., Mitsuma T., et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32 (1992) 707-710
4. Penney Jr. J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., and Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41 (1997) 689-692
5. Shimada N., Sobue G., Doyu M., Yamamoto K., Yasuda T., Mukai E., et al. X-linked recessive bulbospinal neuronopathy: clinical phenotypes and CAG repeat size in androgen receptor gene. Muscle Nerve 18 (1995) 1378-1384
6. Paulson H.L., and Fischbeck K.H. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 19 (1996) 79-107
7. Klockgether T., Kramer B., Ludtke R., Schols L., and Laccone F. Repeat length and disease progression in spinocerebellar ataxia type 3. Lancet 348 (1996) 830
8. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145 (1997) 205-211
9. Krishna N., Mohan S., Yashavantha B.S., Rammurthy A., Kiran Kumar H.B., Mittal U., et al. SCA 1, SCA 2 & SCA 3/MJD mutations in ataxia syndromes in southern India. Indian J Med Res 126 (2007) 465-470
10. Furtado S., Suchowersky O., Rewcastle B., Graham L., Klimek M.L., and Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 39 (1996) 132-136
11. Illarioshkin S.N., Igarashi S., Onodera O., Markova E.D., Nikolskaya N.N., Tanaka H., et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol 36 (1994) 630-635
12. Kieburtz K., MacDonald M., Shih C., Feigin A., Steinberg K., Bordwell K., et al. Trinucleotide repeat length and progression of illness in Huntington's disease. J Med Genet 31 (1994) 872-874